
The 70% Cancer Survival Myth: Who Really Profits From This 'Milestone'?
The US celebrates 70% cancer survival, but this headline masks a brutal truth about access, cost, and the 'forgotten' diagnoses.

The US celebrates 70% cancer survival, but this headline masks a brutal truth about access, cost, and the 'forgotten' diagnoses.

Russian scientists unveil a breakthrough cancer treatment technology. But the real story isn't the science; it's the geopolitical chessboard.

The 'guerrilla war on science' waged by political actors isn't just about abortion; it's a chilling blueprint for dismantling evidence-based medicine.

The recent Summit on Cancer Health Disparities (SCHD26) promised change, but the real fight against cancer health disparities is being ignored.

New research exposes the hidden survival trick of cancer relapse. This isn't just bad luck; it's engineered resilience we must confront.

PSG Hospitals' 2025 conference signals a shift in cancer care, but the real battleground is your plate, not just chemotherapy.